Related Experiment Videos
Identification of a pharmaceutical packaging off-odor using solid phase microextraction gas chromatography/mass
S L Sides1, K B Polowy, A D Thornquest
1Pharmaceutical Development Division, Glaxo Wellcome Inc., Five Moore Drive, Research Triangle Park, NC 27709, USA.
Journal of Pharmaceutical and Biomedical Analysis
|May 30, 2001
Summary
A novel solid phase microextraction (SPME) method identified ethyl-2-mercaptoacetate as the cause of off-odors in heat-stressed pharmaceutical packaging. This trace compound was previously undetectable, highlighting SPME
Area of Science:
- Analytical Chemistry
- Materials Science
- Pharmaceutical Science
Background:
- Off-odors in pharmaceutical packaging can compromise product quality and patient safety.
- Heat stress can induce degradation reactions in packaging materials, leading to volatile compound formation.
- Conventional headspace sampling may fail to detect trace-level odorants.
Purpose of the Study:
- To identify the specific volatile compound responsible for an off-odor in heat-stressed pharmaceutical packaging.
- To evaluate the effectiveness of solid phase microextraction (SPME) coupled with gas chromatography/mass spectrometry (GC/MS) for trace odorant analysis.
- To elucidate the chemical pathway leading to the formation of the identified odorant.
Main Methods:
- Solid phase microextraction (SPME) using a polydimethylsiloxane (PDMS) coated microfiber.
- Gas chromatography/mass spectrometry (GC/MS) for separation and identification of volatile compounds.
- Analysis of heat-stressed pharmaceutical packaging material.
Main Results:
- Ethyl-2-mercaptoacetate was identified as the causative agent of the off-odor.
- The odor compound was present at trace levels, below the detection limit of conventional headspace techniques.
- The formation of ethyl-2-mercaptoacetate resulted from the reaction between ethanol and components of a polyvinyl chloride (PVC)-resin thermal stabilizer.
Conclusions:
- SPME-GC/MS is a powerful technique for identifying trace volatile compounds in pharmaceutical packaging.
- Unanticipated reactions involving residual solvents and packaging additives can lead to significant odor issues.
- Understanding these reactions is crucial for preventing off-odor development in pharmaceutical packaging.